1 month Elevance Health (NYSE:ELV) PT Lowered to $501.00MarketBeat
Barclays dropped their price objective on Elevance Health from $622.00 to $501.00 and set an “overweight” rating on the stock in a research report on Tuesday.
XBarclays dropped their price objective on Elevance Health from $622.00 to $501.00 and set an “overweight” rating on the stock in a research report on Tuesday.
X